# Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD

> **NCT01025739** · PHASE2 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)

## Interventions

- **DEVICE:** EsophyX™ system with SerosaFuse fasteners

## Key facts

- **NCT ID:** NCT01025739
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding source for device purchasing
- **Last updated:** 2015-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025739, "Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01025739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*